Literature DB >> 22492823

Removal of water-soluble and protein-bound solutes with reversed mid-dilution versus post-dilution haemodiafiltration.

Sunny Eloot1, Annemieke Dhondt, Mieke Van Landschoot, Marie-Anne Waterloos, Raymond Vanholder.   

Abstract

BACKGROUND: Convective dialysis strategies are superior in the removal of protein-bound uraemic retention solutes. Mid-dilution and mixed-dilution haemodiafiltration (HDF), both combining pre-dilution and post-dilution, are promising options to further improve removal capacity and have been shown of additional benefit for large middle molecules. In this study, we compared the removal of small water-soluble and protein-bound solutes in post-dilution versus mid-dilution HDF.
METHODS: Fourteen chronic haemodialysis (HD) patients were included in this crossover study. Patients were kept for 4 weeks on high-flux HD. On the mid-week session of Weeks 3 and 4, either post-dilution or reversed mid-dilution HDF were applied, in random order. Blood and dialysate flows were maintained at 300 and 800 mL/min, while the substitution flow was 75 mL/min in post-dilution and 150 mL/min in mid-dilution HDF. Based on the data collected during the sessions under study, extraction ratio (ER) and reduction ratio (RR) of small water-soluble and protein-bound solutes were calculated, as well as total solute removal (TSR) based on spent dialysate.
RESULTS: No differences were observed for TSR, ER and RR for protein-bound solutes. For small water-soluble solutes, ER in post-dilution HDF was significantly higher than in mid-dilution HDF: 0.92 ± 0.02 versus 0.87 ± 0.04 for urea (P < 0.001), 0.92 ± 0.02 versus 0.88 ± 0.02 for creatinine (P < 0.001) and 0.84 ± 0.02 versus 0.82 ± 0.03 for uric acid (P = 0.009). TSR and RR were, however, not different due to the lower inlet concentrations with post-dilution HDF.
CONCLUSIONS: TSR of mid-dilution and post-dilution HDF was not different for both small water-soluble and protein-bound compounds. Both strategies in the setting as applied in this study are as adequate for the removal of these solutes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492823     DOI: 10.1093/ndt/gfs060

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  5 in total

1.  Removal of Dolutegravir by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease.

Authors:  José Moltó; Fredzzia Graterol; Cristina Miranda; Saye Khoo; Ioana Bancu; Alieu Amara; Anna Bonjoch; Bonaventura Clotet
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

2.  Dialyzer Reuse and Outcomes of High Flux Dialysis.

Authors:  Christos Argyropoulos; Maria-Eleni Roumelioti; Abdus Sattar; John A Kellum; Lisa Weissfeld; Mark L Unruh
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

Review 3.  Revisiting the Middle Molecule Hypothesis of Uremic Toxicity: A Systematic Review of Beta 2 Microglobulin Population Kinetics and Large Scale Modeling of Hemodialysis Trials In Silico.

Authors:  Maria Eleni Roumelioti; Thomas Nolin; Mark L Unruh; Christos Argyropoulos
Journal:  PLoS One       Date:  2016-04-07       Impact factor: 3.240

4.  Serum Levels and Removal by Haemodialysis and Haemodiafiltration of Tryptophan-Derived Uremic Toxins in ESKD Patients.

Authors:  Joosep Paats; Annika Adoberg; Jürgen Arund; Annemieke Dhondt; Anders Fernström; Ivo Fridolin; Griet Glorieux; Liisi Leis; Merike Luman; Emilio Gonzalez-Parra; Vanessa Maria Perez-Gomez; Kristjan Pilt; Didier Sanchez-Ospina; Mårten Segelmark; Fredrik Uhlin; Alberto Arduan Ortiz
Journal:  Int J Mol Sci       Date:  2020-02-23       Impact factor: 5.923

5.  Is Fluorescence Valid to Monitor Removal of Protein Bound Uremic Solutes in Dialysis?

Authors:  Jürgen Arund; Merike Luman; Fredrik Uhlin; Risto Tanner; Ivo Fridolin
Journal:  PLoS One       Date:  2016-05-26       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.